Ziyou Lin

机构：Tongji University · ORCID：0000-0002-3657-5004

发表论文 36 篇 · 总被引 2337 次 · h-index 11

代表论文

• Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer (2023 · Cancer Research · 被引 143)
• Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer (2023 · Cancer Letters · 被引 88)
• Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia (2023 · Journal of Hematology & Oncology · 被引 36)
• Discovery and Optimization of Novel Biphenyl Derivatives Bearing Cyclopropyl Linkage as Potent Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors (2023 · Journal of Medicinal Chemistry · 被引 26)
• Comprehensive multi-omics analysis of nucleotide metabolism: elucidating the role and prognostic significance of UCK2 in bladder cancer (2025 · Functional & Integrative Genomics · 被引 6)
• KLRD1 (CD94): A Prognostic Biomarker and Therapeutic Candidate in Head and Neck Squamous Cell Carcinoma (2024 · Journal of Cancer · 被引 6)